February/March 2013

Teasing out valuable data from a sea of text is no mean feat, as Felix Grant discovers

Siân Harris reports on the important role of computing in drug discovery

Beth Harlen presents two case studies exploring how modelling and simulation are changing the face of medical research

Chemistry software will be split between expert tools for computational chemists and 3D desktop modelling tools to support the work of medicinal chemists, says Dr Martin Slater, director of consulting at Cresset

Is HPC becoming an integral part of drug discovery? Industry experts explore the trends

In the battle for processor dominance, who will win out? John Barr weighs up the contenders

The unique requirements of contract research organisations (CROs) demand the deployment of sophisticated informatics systems, as Beth Harlen discovers